124 high-performance-computing-postdoc positions at University of Newcastle in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
through data. It delivers a flexible rolling programme of collaborative projects that focus on a specific business challenge or opportunity and transfers practical data skills into the workforce. Using
-
Patterson Foundation and is aimed at generating pilot data to support further funding applications. We are looking for a motivated researcher to join our group to perform transcriptomics and functional assays
-
Substantial experience in conducting research, as evidenced by impactful publications in high-quality peer-reviewed journals Strong track-record of involvement in successful research funding applications
-
rapidly acquire new skills Detailed knowledge of statistical methods Likelihood of advanced skills directly related to biostatistics High level of analytical and problem-solving capability Ability
-
, management, and development of the University’s Educational Psychology (DAppEdPsy) programme. You will have knowledge and understanding of contemporary research and development in the field of Educational
-
have experience of assuming responsibility for tasks/activities within research projects and be interested in supporting and mentoring junior researchers. You will have successfully published high
-
the highest standards of research integrity and compliance. This is a high-profile role working across the Faculties and liaising externally including with funding bodies and government agencies. Informal
-
pleased to offer a 0.2 FTE post for a period of two years to support our new undergraduate Cognitive Science Programme. We are interested in applicants from diverse backgrounds in Cognitive Science who can
-
encompass (i) the director role of the Doctorate in Clinical Psychology (DClinPsy) programme and (ii) management of two further postgraduate clinical programmes (the Low Intensity and postgraduate diploma in
-
well-characterised tumour models, the research will identify and validate new drug targets that are specifically lethal to tumour cells lacking SMARCB1. The ultimate goal is to generate high-quality